Results 31 to 40 of about 434,626 (386)
A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users [PDF]
, 2006 BACKGROUND Hepatitis C (HCV) prevalence is most common amongst injecting drug users where up to 98% of the population can be infected despite a low prevalence of HIV.
Tompkins, C.N.E., Wright, N.M.J.
core +3 more sources
The Professional Medical Journal, 2015 Objective: To find out the risk factors associated with HCV disease and evaluatethe association of risk factors of HCV disease patient’s in the population of Multan District. StudyDesign: Experimental study. Setting: Nishter Hospital of Multan District. Period: 1st January2011 to 1st April 2012.
Muhammad Amin +3 more
openaire +2 more sources
Virulence, 2021 Involvement of extracellular nicotinamide phosphoribosyltransferase (eNAMPT, i.e., visfatin or pre-B-cell colony-enhancing factor), a cancer metabokine, in chronically hepatitis C virus (HCV)-infected (CHC) patients with sustained virological responses ...
Ming-Ling Chang +5 more
doaj +1 more source
Association of Hepatitis C viral load with liver functions and risk factors among HCV patients, Minia governorate, Egypt [PDF]
Novel Research in Microbiology Journal, 2021 Hepatitis C virus (HCV) is one of the blood transmitted hepatitis viruses. HCV infections have been identified as major causes of chronic hepatic diseases, and hepatocellular carcinoma. The aims of the current study were to determine the HCV viral load
Hala, R. Ahmed +5 more
doaj +1 more source
Hepatitis C virus 3'UTR regulates viral translation through direct interactions with the host translation machinery. [PDF]
, 2013 The 3' untranslated region (3'UTR) of hepatitis C virus (HCV) messenger RNA stimulates viral translation by an undetermined mechanism. We identified a high affinity interaction, conserved among different HCV genotypes, between the HCV 3'UTR and the host ...
Bai, Yun +2 more
core +2 more sources
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
New England Journal of Medicine, 2014 BACKGROUND Effective treatment for hepatitis C virus (HCV) genotype 1 infection in patients who have not had a sustained virologic response to prior interferon-based therapy represents an unmet medical need.
N. Afdhal +24 more
semanticscholar +1 more source
Comparison of HCV core antigen and anti-HCV with HCV RNA results
African Health Sciences, 2015 The measurement of anti-HCV antibodies using immunological methods and the confirmation of viral nuclear acid based on molecular methods is important in diagnosis and follow-up of the HCV infection.In this study, we aimed to analyse HCV core Antigen positivity among anti-HCV antibody positive sera to determine the significance of testing of HCV core Ag
Ayse, Aynali +4 more
openaire +6 more sources
Virulence, 2021 Toll-like receptors (TLRs) are essential for the protection of the host from pathogen infections by initiating the integration of contextual cues to regulate inflammation and immunity.
Jian Shang +10 more
doaj +1 more source
Canada Communicable Disease Report, 2021 Background: Hepatitis C virus (HCV) transmission has been epidemiologically linked to healthcare settings, particularly out-of-hospital settings such as endoscopy clinics and hemodialysis clinics. These have been largely attributed to lapses in infection
Arianne Folkema +7 more
doaj +1 more source
Association Between DEPDC5 and PNPLA3 Variants and the Risk of Hepatocellular Carcinoma in HCV-Infected Patients in Egypt [PDF]
Journal of Bioscience and Applied ResearchHepatocellular carcinoma (HCC) is the most prevalent and life-threatening form of liver cancer worldwide. In Egypt, HCC ranks as the second most common cancer in men and the sixth most common in women.
Osama Roshdy +4 more
doaj +1 more source